1. Home
  2. Analysis
  3. Metformin
  4. Ellence

Metformin and Ellence drug interactions for women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Drug interactions are found for women aged 60+ who take Metformin (metformin hydrochloride) and Ellence (epirubicin hydrochloride) together. We list drug interactions by the duration when the drugs are taken. This phase IV study is created by eHealthMe based on reports of 12 people from the FDA, and is updated regularly.

On Aug, 05, 2026

12 women aged 60+ who take Metformin, Ellence and have drug interactions are studied.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,355 Metformin users. Check the latest studies of Metformin.

What is Ellence?

Ellence has active ingredients of epirubicin hydrochloride. eHealthMe is studying from 943 Ellence users. Check the latest studies of Ellence.

Number of reports submitted per year:

Metformin and Ellence drug interactions in women aged 60+.

Most common drug interactions over time *:

< 1 month:

  1. Alopecia (absence of hair from areas of the body)
  2. Emotional distress

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Alopecia (absence of hair from areas of the body)
  2. Emotional distress
  3. Anxiety
  4. Psychological trauma
  5. Hair colour changes
  6. Hair disorder
  7. Pain

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and Ellence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, metformin hydrochloride and epirubicin hydrochloride (the active ingredients of Metformin and Ellence, respectively), and Metformin and Ellence (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.